How is the Coherus Biosciences Inc today?

The Coherus Biosciences Inc today is trading in the down by -2.50% at 0.78.

How has Coherus Biosciences Inc performed historically?

The Coherus Biosciences Inc is currently trading down -2.50% on an intraday basis in the past week the index rose 2.63%. The index has been down -29.73% in the past quarter and fell -57.14% in the past year. You can view this in the overview section.

What is Coherus Biosciences Inc Annual Revenue?

Coherus Biosciences Inc Annual Revenue rose 3.78%, in the last year to $266.96 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Coherus Biosciences Inc Annual Net Profit?

Coherus Biosciences Inc Annual Net Profit rose 111.98% in the last year to $28.51 M. Its sector's average net profit growth for the last fiscal year was -11.09%.

What is Coherus Biosciences Inc Price to Earning Ratio?

Coherus Biosciences Inc Price to Earning Ratio is -0.69, which is negative.

What is Coherus Biosciences Inc Stock Price?

Coherus Biosciences Inc Stock Price fell 57.14% and underperformed its sector by 112.61% in the past year.

What is Coherus Biosciences Inc Quarterly Revenue?

Coherus Biosciences Inc Quarterly Revenue rose 229.25% YoY to $7.6 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Coherus Biosciences Inc Quarterly Net profit?

Coherus Biosciences Inc Quarterly Net profit fell 154.99% YoY to $56.57 M. Its sector's average net profit growth YoY for the quarter was -212.88%.

What is Coherus Biosciences Inc Mutual Fund Holding?

Coherus Biosciences Inc Mutual Fund Holding decreased by 0.85% in the last quarter to 31.62.

What is Coherus Biosciences Inc Promoter Share Holding?

Coherus Biosciences Inc Promoter Share Holding stayed the same in the most recent quarter at 1%.

What is Coherus Biosciences Inc Interest Coverage Ratio?

Coherus Biosciences Inc Interest Coverage Ratio is 2.05, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

What is Coherus Biosciences Inc Institutional Holding?

Coherus Biosciences Inc Institutional Holding decreased by 4.79% in the last quarter to 53.15.

Coherus Biosciences Inc XNAS: CHRS

Coherus Biosciences Inc Live Share Price Today, Share Analysis and Chart

Name: Coherus Biosciences Inc: Is Infosys Ltd. worth buying?
Item: Coherus Biosciences Inc
Rating: 1.01200
Author: Trendlyne DVM scores

about

Coherus BioSciences Inc is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of innovative immunotherapies to treat cancer. Coherus is developing an innovative immuno-oncology pipeline which inclu...

0.78 -0.02 (-2.50%)

67.90% Fall from 52W High

748.9K XNAS Volume

XNAS 30 May, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Coherus Biosciences Inc is on 11 Jun 2025 for the purpose of Coherus BioSciences Inc Annual General Meeting for 2025 See details

Not Eligible

Expensive Valuation

15.5 / 100

Technically Bearish

25.0 / 100

1Yr Price target upside is 500%

3 analysts

Coherus Biosciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Coherus Biosciences Inc Live Share Price Today, Share Analysis and Chart

Coherus BioSciences Inc is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of innovative immunotherapies to treat cancer. Coherus is developing an innovative immuno-oncology pipeline which inclu...

67.90% Fall from 52W High

SWOT Analysis

Coherus Biosciences Inc Live Price Chart

Coherus Biosciences Inc FAQ

How is Coherus Biosciences Inc today?

Coherus Biosciences Inc today is trading in the red, and is down by -2.50% at 0.78.

How has Coherus Biosciences Inc performed historically?

Coherus Biosciences Inc is currently trading down -2.50% on an intraday basis. In the past week the stock rose 2.63%. stock has been down -29.73% in the past quarter and fell -57.14% in the past year. You can view this in the overview section.